Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print RSS Feed

Breaking News

Related Searches:

July 7, 2010
NextPharma has added a new bottle filling line for tablets at its Göttingen facility in Germany.  Read More »

July 7, 2010
Move follows acquisition in Italy  Read More »

July 6, 2010
Pharmatech Oncology to help run Phase II Ranpirnase trial  Read More »

July 6, 2010
Hunt named as BD VP  Read More »

July 6, 2010
Quintiles boosts clinical infrastructure in Asia  Read More »

July 6, 2010
New chief medical officer has CNS experience  Read More »

July 2, 2010
Eli Lilly and Co. and will acquire Alnara Pharmaceuticals, a privately held biotech company developing protein therapeutics for the treatment of metabolic diseases.  Read More »

July 2, 2010
ThermoSafe Brands Europe has opened its facility in Mallow, Cork, Ireland.  Read More »

July 2, 2010
ClinTec International has expanded into the U.S. market with the launch of its New York office and the appointment of Susan Pavone, associate director of U.S. Business Operations.  Read More »

July 1, 2010
GlaxoSmithKline and Aptuit, Inc. have finalized an agreement for Aptuit to acquire operations at GSK’s Medicines Research Centre in Verona, Italy.  Read More »

July 1, 2010
Eisai Inc., the U.S. operation of Tokyo-based Eisai Co., Ltd., has entered into an agreement with Arena Pharmaceuticals for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential treatment of obesity, including weight loss.  Read More »

July 1, 2010
George A. Scangos, Ph.D. has been appointed chief executive officer of Biogen Idec, effective July 15.  Read More »

July 1, 2010
Sanofi-aventis has entered an agreement to acquire TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors.   Read More »

June 30, 2010
JHP Pharmaceuticals has entered into a multi-year contract supply agreement with an undisclosed ophthalmic company.   Read More »

June 30, 2010
Celgene Corp. and Abraxis BioScience have signed a definitive merger agreement under which Celgene will acquire Abraxis for approximately $2.9 billion.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On